25 results for “Microbiome Therapeutics”. Showing 25 of 39,449.
Epigenetics and the gut-brain axis: Insights into DNA methylation, aging, and Alzheimer disease.
therapeutic benefits of using microbiome modulators, dietary modifications, and pharmacological
The link between gut microbiome and Alzheimer's disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease.
microbiome-related therapeutic strategies for AD. Finally, we discuss current
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases.
microbiome for therapeutics. However, gut microbes and their metabolites have
Microbiome and Postbiotics in Skin Health.
microbiome varies across skin types and anatomical sites, with sebaceous, moist, and dry areas fostering distinct microbial communities. Emerging therapeutic
Neurodegenerative Disorders and the Gut-Microbiome-Brain Axis: A Literature Review.
microbiome-brain axis, which is being explored for therapeutic potential
Akkermansia muciniphila: A double-edged sword in life-stage-specific nutritional modulation of Parkinson's disease via the gut-brain axis.
pave the way for novel microbiome-based precision therapeutics against neurodegeneration.
Recognizing depression as an inflammatory disease: the search for endotypes.
therapeutic strategies. The intestinal microbiome emerges as a crucial modulator
Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity.
therapeutic potential of microbiome-targeted interventions, such as fecal microbiota
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peripheral Inflammatory Networks.
Therapeutic strategies targeting the immuno-glial interface, including selective NLRP3 inhibitors, TREM2 agonists, anti-cytokine biologics, and microbiome
Rewiring the Brain Through the Gut: Insights into Microbiota-Nervous System Interactions.
therapeutic interventions targeting the microbiome to manage neurogastroenterological and even
Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights.
therapeutic application of microbiome-based modalities has received escalating attention
The gut microbiome in neurological disorders.
microbiome can yield novel therapeutic strategies. Systems biology approaches will
Estrogen-gut microbiome axis: Physiological and clinical implications.
therapeutic interventions manipulating the gut microbiome and the metabolic profile
Substance-Induced Psychiatric Disorders, Epigenetic and Microbiome Alterations, and Potential for Therapeutic Interventions
Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer's pathology in App-knock-in mice.
therapeutically utilized to alter the gut microbiome and prevent AD progression
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's disease - Mechanisms and therapeutic frontiers.
Therapeutic approaches that target these interacting pathways are rejuvenation of microglia with senolytics and stimulation of TREM2; regulation of gut microbiota with probiotics, prebiotics, lifestyle modification, dietary intervention; and fecal
Sex-dependent locus coeruleus vulnerability in Alzheimer's disease: gut dysbiosis as a driver and probiotic intervention as rescue.
therapeutic windows for early intervention, including microbiome restoration, neuromodulatory tuning
Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
The gut microbiota has been demonstrated to be correlated with
Microbiota-driven mechanisms in multisystem diseases: integrative evidence across cardiovascular, metabolic, neurological and autoimmune disorders.
therapeutic interventions aimed at restoring microbial homeostasis, including targeted dietary strategies, probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and microbiome
Pain-resolving immune mechanisms in neuropathic pain.
microbiome. Specialized pro-resolving mediators and therapeutic approaches that target
Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
therapeutic management by either altering the gut microbiome composition or supplementing
The microbiome and eating disorders: a new framework at the interface of interoception and reward.
microbiome as a possible mechanism underlying eating disorders, as well as a potential therapeutic
Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment.
microbiome research have spotlighted postbiotics and psychobiotics as innovative therapeutic
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications
In this review, we explore how short-chain fatty acids
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.
In this review, we explore how short-chain fatty acids